Surging global prevalence of schizophrenia and chronic psychiatric disorders, expanding clinical recognition of non-adherence as a primary driver of acute relapse and psychiatric hospitalization, and continuous neuropharmacological innovations in long-acting injectable (LAI) antipsychotics are driving rapid growth across the global Long Acting Schizophrenia Drug Market. Long-acting...
